ReviewCurrent medicinal chemistry2024
Developments of Fms-like Tyrosine Kinase 3 Inhibitors as Anticancer Agents for AML Treatment.
Chenchen Ma et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ReviewCurrent medicinal chemistry2024
Chenchen Ma et al.PubMed ↗Publisher ↗
No numbers read from the abstract.